Subjective Cognitive Decline Clinical Trial
Official title:
Effects of Cognitive Strategy Training on Daily Function in People With Subjective Cognitive Decline
Verified date | March 2020 |
Source | National Cheng Kung University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Subjective cognitive decline (SCD) is the transitional state between normal aging and mild
cognitive impairment. SCD is defined as having self-perceived declines in any cognitive
domain over time; having normal performance on cognitive testing; no dementia or depression.
Cognitive difficulties can lead to a decline on daily function and quality of life. Early
intervention can prevent SCD from developing into dementia.
Cognitive strategy training (CST) aims to generate individualized strategies to solve
cognitive problems, which can be effective to improve daily functions and performances.
However, there is limited clinical research aimed at improving daily functions for SCD. Most
non-pharmacological studies have conducted objective cognitive training, which may not
enhance daily performance. Previous studies also seldom examine the effectiveness of the
intervention to improve daily function, quality of life, self-efficacy and motivation.
This study adopts a quasi-experimental design. The investigators will recruit 80
community-dwelling people with SCD who are aged 55 and older. There will be 40 participants
in each group. The experimental group will receive the CST. The active control group will
receive group interactive game. Both groups will have 8 sessions for one hour per week for a
total of 8 weeks. Outcome measures include daily function, self-efficacy, motivation for
change, and quality of life. Assessments will be performed at baseline, post-intervention,
and 3-month follow-up. The demographic data of the two groups will be compared using the
independent sample t-test and chi-square test. Changes on outcomes between the two groups
will be analyzed by two-way ANOVA. This study was approved by the Human Research Ethics
Committee at National Cheng Kung University. All participants provided written informed
consent before testing.
This study aims to (1) examine the feasibility of the CST in community-dwelling people with
SCD; (2) explore the efficacy of the CST on daily function, self-efficacy, motivation for
change, and quality of life.
Status | Active, not recruiting |
Enrollment | 80 |
Est. completion date | December 31, 2020 |
Est. primary completion date | October 31, 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 55 Years and older |
Eligibility |
Inclusion Criteria: - aged 55 and above - live in community - self-perceived decline in cognition compared to five years ago - subjective cognitive decline, Cognitive Failure Questionnaire (CFQ) score above zero. Exclusion Criteria: - objective cognitive impairment, Taiwanese version of the Montreal Cognitive Assessment (MoCA-T) scores below 24 - any medical, neurological or psychiatric disorders, Brief Symptom Rating Scale (BSRS-5) scores 10 or more - severe visual, auditory, verbal or physical impairments interfere with communication, command compliance, and strategy execution - participate in other research related to cognitive strategy at the same time. |
Country | Name | City | State |
---|---|---|---|
Taiwan | Department of Occupational Therapy, College of Medicine, National Cheng Kung University | Tainan |
Lead Sponsor | Collaborator |
---|---|
National Cheng Kung University |
Taiwan,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change from Baseline Canadian Occupational Performance Measure-Chinese version (COPM-C) at post-intervention, and 3-month follow-up. | Canadian Occupational Performance Measure-Chinese version (COPM-C) is a semi-structured interview questionnaire used to assess self-perceived problems in occupational performance areas. Participants need to identify cognitive-related occupational performance problems, then score the importance from 1 to 10. The higher the score, the more important it is. Participants also need to score their performance and satisfaction from 1 to 10 on the first five important issues. Higher scores mean a better outcome. |
Assessments will be performed at baseline, within one week after the intervention, and 3-month follow-up after the intervention. . | |
Secondary | Change from Baseline General Self-Efficacy Scale (GSE) at post-intervention, and 3-month follow-up. | General Self-Efficacy Scale (GSE) is a self-reported questionnaire used to assess individual beliefs of how effective they are in facing stress and challenges. The scale scores range from 10 to 40, with higher scores indicating better self-efficacy. | Assessments will be performed at baseline, within one week after the intervention, and 3-month follow-up after the intervention. | |
Secondary | Change from Baseline Contemplation ladder at post-intervention, and 3-month follow-up. | Contemplation ladder is an 11-point scale used to assess readiness and motivation for change before action. The scale score is between 0 and 10, with higher scores indicating greater motivation for change. | Assessments will be performed at baseline, within one week after the intervention, and 3-month follow-up after the intervention. | |
Secondary | Change from Baseline COOP/WONCA (World Organization of Family Doctors) charts at post-intervention, and 3-month follow-up. | COOP/WONCA (World Organization of Family Doctors) is a self-reported chart used to assess health-related quality of life. The scale scores range from 6 to 30, with lower scores indicating better quality of life. | Assessments will be performed at baseline, within one week after the intervention, and 3-month follow-up after the intervention. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT04121728 -
Modulation of Attention in Event Related Potential (ERPs) as a Marker of Early Cognitive Decline by Ginkgo Biloba
|
N/A | |
Active, not recruiting |
NCT03271190 -
Impact of a Cognitive Intervention Enriched With Leisure Activities in Persons With Subjective Cognitive Decline
|
N/A | |
Recruiting |
NCT06078748 -
The Lifestyle Exercise and Diet Trial (LEAD) 2.0
|
N/A | |
Recruiting |
NCT06287489 -
Effects of Mediterranean Diet on Subjective Cognitive Decline
|
N/A | |
Recruiting |
NCT05331144 -
Impact of Intensive Treatment of SBP on Brain Perfusion, Amyloid, and Tau (IPAT Study)
|
Phase 2 | |
Completed |
NCT02969460 -
Neurotrack Virtual Cognitive Health Study
|
N/A | |
Completed |
NCT03495037 -
Preventing Cognitive and Functional Decline Among Seniors at Risk
|
N/A | |
Recruiting |
NCT06095063 -
dTMS for Subjective Cognitive Decline
|
N/A | |
Recruiting |
NCT06110858 -
Efficacy of Tinkering Activities in Individuals With Subjective Cognitive Decline
|
N/A | |
Enrolling by invitation |
NCT03772977 -
The Brain Health Champion Study
|
N/A | |
Completed |
NCT03236454 -
tDCS-enhanced Working Memory Training in Subjective Cognitive Decline
|
N/A | |
Not yet recruiting |
NCT06358404 -
Developing a Peer Support Intervention for Depression in SCD
|
N/A | |
Completed |
NCT04796415 -
DEMA-Pro Intervention for Seniors With Subjective Cognitive Decline and Living at Home
|
N/A | |
Completed |
NCT04439500 -
Effects of Online Training Aimed at Increasing Participation in Everyday Life During a Pandemic (SCD Online).
|
N/A | |
Completed |
NCT04880252 -
Neuropsychological Indicators of SCD Progression
|
||
Completed |
NCT04265378 -
Cognitive Training and Brain Stimulation in Prodromal Alzheimer's Disease
|
N/A | |
Completed |
NCT03370744 -
Prediction of Cognitive Decline by Neuroimaging Techniques and the Application in Diagnosis and Treatment of Preclinical AD
|
||
Recruiting |
NCT06335836 -
The Effects of Social Isolation and Social Interaction on the Risk of Dementia Progression and Brain Function in SCD (Subjective Cognitive Decline, SCD)
|
||
Not yet recruiting |
NCT05225181 -
Effects of the Combining Physical Exercise and Cognitive Training for the Community-based Elderly
|
N/A | |
Recruiting |
NCT05756270 -
Clinical Applicability of pCASL as a Substitute for FDG-PET in MCI and SCD Patients
|